Name: MLTX Balance Sheet - Moonlake Immunotherapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

MLTX - Moonlake Immunotherapeutics

USD | NASDAQ | Healthcare

MLTX Balance Sheet - Moonlake Immunotherapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Cash And Short Term Investments
Cash And Equivalents	334.5	180.4	451.2	39.5	8.0	1.3
Restricted Cash	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-
Cash And Short Term Investments	334.5	180.4	451.2	39.5	8.0	1.3
Receivables
Accounts Receivable	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-
Prepaid Expenses	22.9	23.4	2.1	4.2	1.4	0.3
Other Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-
Current Liabilities
Accounts Payable	-	-	-	-	-	-
Short Term Debt	-	-	-	0.0	15.0	-
Deferred Revenue Current
Non-Current Liabilities
Long Term Debt	74.1	0.0	-	-	-	-
Operating Lease Liabilities Non-Current	0.4	1.5	2.5	0.1	0.0	-
Common Equity
Common Stock	-	-	-	-	0.0	0.0
Additional Paid In Capital	766.8	677.4	610.0	129.2	42.1	5.1
Retained Earnings
Supplementary Data
Total Debt	74.1	0.0	-	0.0	15.0	-
Net debt	(260.4)	(180.4)	-	(39.5)	7.0	-
Working Capital

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20
Cash And Short Term Investments
Cash And Equivalents	298.5	334.5	350.7	306.7	271.6	180.4	375.7	342.8	458.4	451.2	318.2	501.8	50.1	39.5	41.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	33.0	22.9	26.7	27.0	23.1	23.4	16.0	15.4	5.0	2.1	3.3	4.0	3.1	4.2	4.5	5.1	0.1	-
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	396.6	421.7	411.2	455.5	506.3	474.3	512.3	536.9	553.6	514.2	500.0	506.4	66.5	76.5	88.5	98.4

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	0.5	0.6	0.6	0.7	0.7	0.7	0.6	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.1	-
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	1.9	1.6	1.9	2.3	2.6	2.9	3.3	3.4	3.7	3.6	0.2	0.2	0.2	0.3	-	-
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	1.3	0.6	0.6	1.7	1.7	0.0	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	3.7	2.7	3.1	4.6	5.0	3.6	5.9	8.0	10.5	12.4	0.2	0.3	0.3	0.3	0.1	0.1	-
Total Assets	400.4	424.4	414.3	460.1	511.3	477.9	518.2	544.9	564.1	526.5	500.2	506.6	66.8	76.8	88.6	98.4	231.2

Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.9	1.2	1.5	1.6	1.4	1.4	1.4	1.3	1.3	1.2	0.2	0.2	0.2	0.2	-	-
Accrued Expenses	2.2	2.3	4.2	3.2	2.5	4.2	2.9	2.0	1.2	2.8	1.6	0.9	0.5	1.1	0.9	0.5	5.8	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	46.1	45.5	48.4	27.4	24.0	22.5	20.1	12.3	8.9	10.0	10.3	7.1	7.3	7.7	6.0	3.9

Non-Current Liabilities
Long Term Debt	99.0	74.1	73.7	73.4	73.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.9	0.4	0.5	0.8	1.1	1.5	1.9	2.0	2.4	2.5	0.0	0.1	0.1	0.1	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	100.2	74.5	74.8	74.8	74.7	2.1	2.6	2.6	2.8	3.1	0.3	0.4	0.4	0.4	0.0	0.0
Total Liabilities	146.4	120.0	123.1	102.2	98.7	24.5	22.7	14.8	11.7	13.0	10.6	7.5	7.7	8.1	6.0	3.9

Common Equity
Common Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	-	0.0	0.0	-	0.0	-
Additional Paid In Capital	786.3	766.8	689.1	684.0	680.7	677.4	675.3	672.0	670.2	610.0	531.3	589.5	131.3	129.2	123.8	122.1	34.2
Retained Earnings	(532.6)	(462.9)	(400.5)	(330.8)	(275.5)	(235.6)	(190.0)	(154.6)	(130.3)	(116.7)	(109.2)	(99.8)	(89.7)	(80.7)	(68.8)	(58.7)	(9.8)
Accumulated Other Comprehensive Income	0.3	0.6	0.3	0.5	2.4	5.0	2.8	3.3	2.7	2.4	2.9	0.0	0.3	0.4	0.2	0.1
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	-	-
Minority Interest	-	-	2.3	4.2	5.1	6.6	7.3	9.4	9.8	17.8	64.7	9.3	17.1	19.9	27.3	31.0	-	-
Total Stockholders Equity	254.0	304.5	288.9	353.7	407.5	446.8	488.2	520.7	542.6	495.7	424.9	489.8	42.0	48.9	55.3	63.5	24.4
Total Equity	254.0	304.5	291.2	357.9	412.6	453.4	495.5	530.0	552.4	513.5	489.6	499.1	59.1	68.8	82.6	94.6	(25.3)	0.1